“The company’s first robot aims to assist in soft tissue surgeries. Called Galen ES, it acts as a support for surgeons performing ear, nose and throat (ENT) surgeries, particularly laryngeal cancer operations. Swappable instruments follow the surgeon’s hand movements but allow the user to take a break if needed. According to Lichorowic, the goal is...
Original Release: https://www.prnewswire.com/news-releases/galen-robotics-announces-over-subscribed-15-million-series-a-to-advance-next-phase-in-surgical-robotics-301663599.html Ambix Healthcare Partners Leads Funding Round Bringing New Surgical Robot To Market BALTIMORE, Nov. 1, 2022 /PRNewswire/ — Galen Robotics, the Digital-Surgery-as-a-Service ™ pioneer, today announced it has completed the 1st close for an oversubscribed Series A round with $15 million in funding, including investment from Ambix Healthcare Partners, from Menlo Park, CA. Galen Robotics has submitted a...
Galen Robotics joined ABC News Good Morning Washington to discuss how the company is on the verge of helping local and community hospitals and surgery centers to have access to the latest equipment and newest technologies through their Surgery-as-a-Service models. Their goal is to expand the benefits of microsurgery and surgical robotics by enabling precise surgical...
Galen News – We are proud to announce that Dr. Robert S. Langer, founder of 40 biotechnology companies, including Moderna, will join the company’s Board of Directors. He will assist Galen Robotics to advance and deliver a new, breakthrough generation of cooperative surgical robots for microsurgery while also launching Digital-Surgery-as-a-Service (a new shared-risk mode for hospitals...
We are proud to announce that Acquisition International Magazine has named Galen Robotics Maryland’s 2021 Leading Innovators in Surgical Robotics Solutions! As a company, we continued to democratize microsurgery and robotic surgery. Galen is developing collaborative surgical robots for microsurgery unaddressed by today’s surgical robots. The vision is to introduce an affordable, per-usage digital surgery “as-a-service” model....
The COVID-19 pandemic has brought radical change to the structure of healthcare operations, causing medical institutions to reevaluate their distribution of resources to better care for their patients and adapt to new economic conditions in a more dynamic economic environment. In this article for MD+DI, Galen Robotics CEO Bruce Lichorowic discusses the potential for shared-risk...
At Galen, we believe collaborative robots that enhance surgical performance are key to the future of robotic surgery. Interestingly, our vision is the same as many industry experts. Read More from the new UK Royal Academy of Surgeons Robotics Whitepaper In the article, experts see the opportunity of collaborative robots that enhance surgical performance. “Collaborative...
Galen News – Galen CTO David Saunders will represent Galen Robotics as a speaker at the MD&M West Conference from August 10th-12th, 2021. MD&M West, presented by Informa Markets, brings together MedTech engineers, business leaders, disruptive companies, and innovative thinkers to create powerful solutions and life-changing medical devices. Dave S. will present twice at this conference, once...
The healthcare sector is struggling from the pressure of skyrocketing costs and need to continuously improve the quality of services. The Covid-19 pandemic only exacerbated the challenge. As a result, the industry is looking forward to new healthcare business models – including Surgery-as-a-Service. Galen CEO Bruce Lichorowic is invited by Robotic Business Review to write...
Galen Robotics, Inc. CEO Bruce Lichorowic took the opportunity to present the technical foundations of the Galen platform as well as the key supporting information and commercialization initiatives intended to ensure that the innovations from Galen will provide tangible improvements in procedure safety and patient health. In this presentation you’ll learn details about the following:...